Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2020

01-01-2020 | Urinalysis | Original article

Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study

Authors: Masahiro Naruse, Masashi Mukoyama, Jun Morinaga, Masanobu Miyazaki, Kunitoshi Iseki, Kunihiro Yamagata

Published in: Clinical and Experimental Nephrology | Issue 1/2020

Login to get access

Abstract

Background

The dipstick urinalysis for proteinuria has been used for chronic kidney disease (CKD) screening at community-based health checkups; however, it has major drawbacks in that the result is only semi-quantitative and is influenced by urine concentration.

Methods

We conducted urine protein/creatinine ratio (UPCR) measurements of 590 participants who showed a result of more than trace proteinuria on a dipstick analysis and evaluated the usefulness of UPCR measurements in community-based health checkups.

Results

The UPCR values increased in accordance with the severity of the dipstick test findings, but statistical significance was only obtained between (±) and (1+), between (±) and (2+), and between (±) and (3+) groups. When the participants with (±) proteinuria were subjected to CGA classification (a classification of CKD by cause, glomerular filtration rate category, and albuminuria category) according to their UPCR data, a significant proportion of subjects (277, 77.0%) moved from the A2 category into A1, which is a less severe category. Conversely, 21 subjects (5.8%) were reclassified into a more severe category (A3). Thus, a dipstick test may produce a non-negligible number of false negatives as well as a large number of false positives. Similarly, the classifications of more than half of the subjects with (1+) or more severe proteinuria were changed based on their UPCR results.

Conclusion

The dipstick urinalysis for proteinuria appears less reliable than expected, suggesting that the quantitative measurement of urine protein should be performed even during mass health checkups to ensure the early detection and prevention of CKD.
Literature
1.
go back to reference Levy AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the national kidney foundation and the US food and drug administration. Am J Kidney Dis. 2009;54:205–26.CrossRef Levy AS, Cattran D, Friedman A, Miller WG, Sedor J, Tuttle K, Kasiske B, Hostetter T. Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the national kidney foundation and the US food and drug administration. Am J Kidney Dis. 2009;54:205–26.CrossRef
2.
go back to reference Iseki K, Ikeyama Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–74.CrossRef Iseki K, Ikeyama Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63:1468–74.CrossRef
3.
go back to reference Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow up study. Kidney Int. 2007;71:159–66.CrossRef Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, Shiigai T, Narita M, Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow up study. Kidney Int. 2007;71:159–66.CrossRef
4.
go back to reference Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, et al. Dipstick proteinuria and all-cause mortality among the general population. Clin Exp Nephrol. 2018;22:1331–400.CrossRef Iseki K, Konta T, Asahi K, Yamagata K, Fujimoto S, Tsuruya K, et al. Dipstick proteinuria and all-cause mortality among the general population. Clin Exp Nephrol. 2018;22:1331–400.CrossRef
5.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.CrossRef
6.
go back to reference Nagai K, Yamagata K. Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method. Clin Exp Nephrol. 2015;19:152–3.CrossRef Nagai K, Yamagata K. Quantitative evaluation of proteinuria for health checkups is more efficient than the dipstick method. Clin Exp Nephrol. 2015;19:152–3.CrossRef
7.
go back to reference White SL, Yu R, Crag JC, Polkinghome KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Kidney Res Clin Pract. 2011;58:19–28. White SL, Yu R, Crag JC, Polkinghome KR, Atkins RC, Chadban SJ. Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Kidney Res Clin Pract. 2011;58:19–28.
8.
go back to reference Sato H, Konta T, Ichikawa K, Suzuki N, Kawabata A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2016;20:611–7.CrossRef Sato H, Konta T, Ichikawa K, Suzuki N, Kawabata A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2016;20:611–7.CrossRef
9.
go back to reference Kondo M, Yamagata K, Hoshi S, Saito C, Asahi K, Moriyama T, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16:279–91.CrossRef Kondo M, Yamagata K, Hoshi S, Saito C, Asahi K, Moriyama T, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16:279–91.CrossRef
10.
go back to reference Kondo M, Yamagata K, Hoshi S, Saito C, Asahi K, Moriyama T, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18:885–91.CrossRef Kondo M, Yamagata K, Hoshi S, Saito C, Asahi K, Moriyama T, et al. Budget impact analysis of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2014;18:885–91.CrossRef
11.
go back to reference Chitalia VC, Kothari J, Wells EJ, Livesey JH, Robson RA, Searle M, et al. Cost-benefit analysis and prediction of 24-h proteinuria from the spot urine protein-creatinine ratio. Clin Nephrol. 2001;55:436–47.PubMed Chitalia VC, Kothari J, Wells EJ, Livesey JH, Robson RA, Searle M, et al. Cost-benefit analysis and prediction of 24-h proteinuria from the spot urine protein-creatinine ratio. Clin Nephrol. 2001;55:436–47.PubMed
12.
go back to reference Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543–6.CrossRef Ginsberg JM, Chang BS, Matarese RA, Garella S. Use of single voided urine samples to estimate quantitative proteinuria. N Engl J Med. 1983;309:1543–6.CrossRef
13.
go back to reference Kosmadakis G, Filiopoulos V, Georgoulias C, Smirloglou D, Draganis T, Michail S. Quantitative evaluation of proteinuria by estimation of the protein/creatinine ratio in a random urine sample. Renal Fail. 2010;32:153–6.CrossRef Kosmadakis G, Filiopoulos V, Georgoulias C, Smirloglou D, Draganis T, Michail S. Quantitative evaluation of proteinuria by estimation of the protein/creatinine ratio in a random urine sample. Renal Fail. 2010;32:153–6.CrossRef
15.
go back to reference Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.CrossRef
16.
go back to reference Kanada Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef Kanada Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.CrossRef
17.
go back to reference Hillege HL, Fidler V, Dierks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–822.CrossRef Hillege HL, Fidler V, Dierks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–822.CrossRef
18.
go back to reference Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813–21.CrossRef Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20:1813–21.CrossRef
19.
go back to reference Yalamati P, Bhongir AV, Karra M, Beedu SR. Comparative analysis of urinary total proteins by bicinchoninic acid and pyrogallol red molybdate methods. J Clin Diagn Res. 2015;9:BC01–4.PubMedPubMedCentral Yalamati P, Bhongir AV, Karra M, Beedu SR. Comparative analysis of urinary total proteins by bicinchoninic acid and pyrogallol red molybdate methods. J Clin Diagn Res. 2015;9:BC01–4.PubMedPubMedCentral
20.
go back to reference Simerville JA, Maxted WC, Pahira JJ. Urinalysis: A comprehensive review. Am Fam Physician. 2005;71:1153–62.PubMed Simerville JA, Maxted WC, Pahira JJ. Urinalysis: A comprehensive review. Am Fam Physician. 2005;71:1153–62.PubMed
21.
go back to reference Tani Y, Nakayama M, Terawaki H, Iseki K, Watanabe T. Comparison of albuminuria test and urine test strip in Japanese hypertensive patients: AVA-E study. Clin Nephrol. 2015;84:270–3.CrossRef Tani Y, Nakayama M, Terawaki H, Iseki K, Watanabe T. Comparison of albuminuria test and urine test strip in Japanese hypertensive patients: AVA-E study. Clin Nephrol. 2015;84:270–3.CrossRef
22.
go back to reference Sato H, Konta T, Ichikawa K, Suzuki N, Kabasawa A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2016;20:611–7.CrossRef Sato H, Konta T, Ichikawa K, Suzuki N, Kabasawa A, Suzuki K, et al. Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol. 2016;20:611–7.CrossRef
23.
go back to reference Wu M-T, Lam K-K, Lee W-C, Hsu K-T, Wu C-H, Cheng B-C, et al. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal. 2012;26:82–92.CrossRef Wu M-T, Lam K-K, Lee W-C, Hsu K-T, Wu C-H, Cheng B-C, et al. Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J Clin Lab Anal. 2012;26:82–92.CrossRef
24.
go back to reference Inagaki K, Yasuda Y, Ando M, Kaihan AB, Hachiya A, Ozeki T, et al. Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission. PLoS ONE. 2017;12:e0187607.CrossRef Inagaki K, Yasuda Y, Ando M, Kaihan AB, Hachiya A, Ozeki T, et al. Seasonal proteinuria changes in IgA nephropathy patients after proteinuria remission. PLoS ONE. 2017;12:e0187607.CrossRef
25.
go back to reference Wada Y, Hamamoto Y, Ikeda H, Honjo S, Kawasaki Y, Mori K. Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with type 2 diabetes and early nephropathy. Diabet Med. 2012;29:506–8.CrossRef Wada Y, Hamamoto Y, Ikeda H, Honjo S, Kawasaki Y, Mori K. Seasonal variations of urinary albumin creatinine ratio in Japanese subjects with type 2 diabetes and early nephropathy. Diabet Med. 2012;29:506–8.CrossRef
26.
go back to reference Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.CrossRef Konta T, Hao Z, Takasaki S, Abiko H, Ishikawa M, Takahashi T, et al. Clinical utility of trace proteinuria for microalbuminuria screening in the general population. Clin Exp Nephrol. 2007;11:51–5.CrossRef
Metadata
Title
Usefulness of the quantitative measurement of urine protein at a community-based health checkup: a cross-sectional study
Authors
Masahiro Naruse
Masashi Mukoyama
Jun Morinaga
Masanobu Miyazaki
Kunitoshi Iseki
Kunihiro Yamagata
Publication date
01-01-2020
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 1/2020
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-019-01789-4

Other articles of this Issue 1/2020

Clinical and Experimental Nephrology 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine